Autoantigens interact with cis-acting elements of rubella virus RNA

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6269-6277

  Pogue, Gregory P ^a,f   Hofmann, Jorg ^b   Duncan, Robert ^a   Best, Jennifer M ^c   Etherington, John ^c,g   Sontheimer, Richard D ^d   Nakhasi, Hira L ^a,e  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f Biosource Technologies Inc   (United States)

^g Millbank   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; VIRUS RNA;

ANIMAL CELL; ARTHRITIS; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; PROTEIN TARGETING; RUBELLA VIRUS; VIRUS GENE;

EID: 0029843988     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6269-6277.1996     Document Type: Article

References (49)

1. Atreya, C. D., G. P. Pogue, N. K. Singh, and H. L. Nakhasi. 1996. Role of calreticulin in rubella virus replication, p. 91-117. In M. Michalak (ed.), Calreticulin, molecular biology intelligence unit. R.G. Landes Co., Austin, Tex.
2. Atreya, C. D., N. K. Singh, and H. L. Nakhasi. 1995. The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain. J. Virol. 69:3848-3851.
3. Best, J. M., J. E. Banatvala, and J. M. Bowen. 1974. New Japanese rubella vaccine: comparative trial. Br. Med. J. 3:221-224.
4. Chambers, J. C., D. Kenan, B. J. Martin, and J. D. Keene. 1988. Genomic structure and amino acid sequence domains of the human La autoantigen. J. Biol. Chem. 263:18043-18051.
5. Chang, Y.-N., D. J. Kenan, J. D. Keene, A. Gatignol, and K.-T. Jeang. 1994. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J. Virol. 68:7008-7020.
6. Chantler, J. K., D. K. Ford, and A. J. Tingle. 1981. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination. Infect. Immun. 32:1274-1280.
7. Chantier, J. K., D. K. Ford, and A. J. Tingle. 1982. Persistent rubella infection and rubella-associated arthritis. Lancet 1:1323-1325.
8. Chantier, J. K., A. J. Tingle, and R. E. Petty. 1985. Persistent rubella virus infection associated with chronic arthritis in children. N. Engl. J. Med. 313:1117-1123.
9. Cheng, S.-T., T. Q. Nguyen, Y. S. Yang, J. D. Capra, and R. D. Sontheimer. Calreticulin binds hyRNA and the 52 KD polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J. Immunol. in press.
10. Cooper, L. Z., P. R. Ziring, H. J. Weiss, B. A. Matters, and S. Krugman. 1969. Transient arthritis after rubella vaccination. Am. J. Dis. Child. 118: 218-225.
11. Davidson, H. W., and C. Watts. 1989. Epitope-directed processing of specific antigen by B lymphocytes. J. Cell Biol. 109:85-95.
12. Dominquez, G., C.-Y. Wang, and T. F. Frey. 1990. Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution. Virology 177:225-238.
13. Dong, X., K. J. Hamilton, M. Satoh, J. Wang, and W. H. Reeves. 1994 Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and the SV40 large T antigen. J. Exp. Med. 179:1243-1252.
14. Ford, D. K., A. J. Tingle, and J. K. Chantier. 1988. In L. Espinoza, D. L. Goldenberg, F. C. Arnett, and G. S. Alarcon (ed.), Infections in the rheumatic diseases, p. 103-106. Grune and Stratton, Orlando, Fla.
15. Francoeur, A. M., and M. B. Mathews. 1982. Interaction between VA RNA and the lupus antigen La: formation of a ribonucleo-protein particle in vitro. Proc. Natl. Acad. Sci. USA 79:6772-6776.
16. Gottlieb, E., and J. A. Steitz. 1989. Function of the mammalian La protein: evidence for its action in transcriptional termination by RNA polymerase III. EMBO J. 8:851-861.
17. Howson, C. P., M. Katz, R. B. Johnston, and H. V. Fineberg. 1992. Chronic arthritis after rubella vaccination. Clin. Infect. Dis. 15:307-312.
18. Keene, J. D., S. Deutscher, D. Kenan, and A. Kelekar. 1987. Nature of the La and Ro RNPs. Mol. Biol. Rep. 12:235-238.
19. Malawista, S. E., and A. C. Steere. 1981. Viral arthritis, p. 1586-1601. In W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge (ed.), Textbook of rheumatology. W. B. Saunders Co., Philadelphia.
20. Maraia, R. J., D. J. Kenan, and J. D. Keene. 1994. Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol. Cell. Biol. 14:2147-2158.
21. McCauliffe, D. P., F. A. Lux, T. S. Lui, I. Sanz, J. Hank, M. M. Newkirk, L. L. Bachinski, Y. Itoh, M. J. Siciliano, M. Reichlin, R. D. Sontheimer, and J. D. Capra. 1990. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J. Clin. Invest. 85:1379-1391.
22. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Lejbkowicz, D. J. Kenan, E. K. L. Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993 La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67:3798-3807.
23. Miki, N. P. H., and J. K. Chantler. 1992. Differential ability of wild-type and vaccine strains of rubella virus to replicate and persist in human joint tissue. Clin. Exp. Rheum. 10:3-12.
24. Nakhasi, H. L., T. A. Rouault, D. J. Haile, T.-Y. Liu, and R. D. Klausner. 1990. Specific high-affinity binding of host proteins to the 3′-region of rubella virus RNA. New Biol. 2:255-264.
25. Nakhasi, H. L., N. K. Singh, G. P. Pogue, X.-Q. Cao, and T. A. Rouault. 1994. Identification and characterization of host factor interactions with cis-acting elements of rubella virus RNA. Arch. Virol. 9(Suppl.):255-267.
26. Nakhasi, H. L., D. Zheng, I. K. Hewlett, and T.-Y. Liu. 1988. Rubella virus replication: effect of interferons and actinomycin D. Virus Res. 10:1-15.
27. Nash, P. D., M. Opas, and M. Michalak. 1994. Calreticulin: not just another calcium-binding protein. Mol. Cell. Biochem. 135:71-78.
28. Ogra, P. L., Y. Chiba, S. S. Ogra, J. L. Dzierba, and J. K. Herd. 1975 Rubella virus infection in juvenile rheumatoid arthritis. Lancet i:1157-1161.
29. Phillips, P. E. 1977. Viruses and systemic lupus erythematosus. Bull. Rheum. Dis. 28:954-959.
30. Pogue, G. P., X.-Q. Cao, N. K. Singh, and H. L. Nakhasi. 1993. 5′ sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins. J. Virol. 67:7106-7117.
31. Pogue, G. P., J. Hofmann, R. Duncan, and H. L. Nakhasi. Unpublished data.
32. Polk, B. F., J. F. Modlin, J. A. White, and P. C. DeGirolami. 1982. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am. J. Epidemiol. 115:19-25.
33. Rinke, J., and J. A. Steitz. 1982. Precursor molecules of both human 5S ribosomal and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies. Cell 29:149-159.
34. Rokeach, L. A., J. A. Haselby, J. F. Meilof, R. J. T. Smeek, T. R. Unnasch, B. M. Greene, and S. O. Hoch. 1991. Characterization of the autoantigen calreticulin. J. Immunol. 147:3031-3039.
35. Rosa, M. D., E. Gottlieb, M. R. Lerner, and J. A. Steitz. 1981. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol. Cell. Biol. 1:785-796.
36. Rosen, A., L. Casciola-Rosen, and J. Ahearn. 1995. Novel packages of viral and self-antigens arc generated during apoptosis. J. Exp. Med. 181:1557-1561.
37. Singh, N. K., C. D. Atreya, and H. L. Nakhasi. 1994. Identification of calreliculin as a rubella virus RNA binding protein. Proc. Natl. Acad. Sci. USA 91:12770-12774.
38. Slater, P. E., T. Ben-Zvi, A. Fogel, M. Ehrenfeld, and S. Ever-Hadani. 1995. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine 13:1529-1532.
39. Spruance, S. L., and C. B. Smith. 1971. Joint complications associated with derivatives of HPV-77 rubella virus vaccine. Am. J. Dis. Child. 122:105-111.
40. St. Clair, E. W., D. Kenan, J. A. Burch, Jr., J. D. Keene, and D. S. Pisetsky. 1990. The fine specificity of anti-La antibodies induced in mice by immunization with recombinant human La autoantigen. J. Immunol. 144:3868-3876.
41. Stefano, J. E. 1984. Purified lupus antigen La recognizes an oligouridylate stretch common to the 3′ termini of RNA polymerase III transcripts. Cell 36:145-154.
42. Svitkin, Y. V., A. Pause, and N. Sonenberg. 1994. La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 68:7001-7007.
43. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:93-151.
44. Tan, E. M. 1994. Autoimmunity and apoptosis. J. Exp. Med. 179:1083-1086.
45. Thompson, G. R., A. Ferreyra, and R. G. Brackett. 1971. Acute arthritis complicating rubella vaccination. Arthritis Rheum. 14:19-26.
46. Tingle, A. J., M. Allen, R. E. Petty, G. D. Kettyls, and J. K. Chantier. 1986. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann. Rheum. Dis. 45:110-114.
47. Tingle, A. J., J. K. Chantler, K. H. Pot, D. W. Paty, and D. K. Ford. 1985. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J. Infect. Dis. 152:606-612.
48. Wilusz, J., M. G. Kurilla, and J. D. Keene. 1983. A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitus virus. Proc. Natl. Acad. Sci. USA 80:5827-5831.
49. Wolinsky, J. S. 1990. Rubella, p. 815-838. In B. N. Fields (ed.), Virology. Raven Press, New York.